News
Hims & Hers Health Post Q2 Earnings – Compounded GLP-1 Ploy Faces New Threats (NYSE:HIMS)
Investment Overview: Hims and Hers Stock Gains On Compounded GLP-1 agonist Drugs, When I last covered Hims & Hers Health…
Bicara Therapeutics Plans $200 Million IPO For Head & Neck Cancer Drug (Pending:BCAX)
A Quick Take On Bicara Therapeutics Bicara Therapeutics Inc. (BCAX) has filed to raise $200 million in an IPO of…
GraniteShares 2x Long COIN ETF: Proof In The Pudding (NASDAQ:CONL)
I last covered the GraniteShares 2x Long COIN ETF (NASDAQ:CONL) for Seeking Alpha in April of this year. At that…
Coming Fed Rate Cuts Will Be No Panacea
Investors are taking Fed Chairman Powell's comments from Jackson Hole last Friday around it is now time for monetary policy…
Jiayin Group Inc. (JFIN) Q2 2024 Earnings Call Transcript
Jiayin Group Inc. (NASDAQ:JFIN) Q2 2024 Earnings Conference Call August 27, 2024 8:00 AM ET Company Participants Shawn Zhang -…
Branicks Group AG 2024 Q2 – Results – Earnings Call Presentation (OTCMKTS:DDCCF)
This article was written byFollowSeeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We…
VerticalScope Holdings: The Undervalued Canadian Reddit (TSX:FORA:CA)
Thesis On March 21, 2024, Reddit (RDDT) went public. Traders and meme stock enthusiasts were drawn in to arguably the…
D.R. Horton: Headwinds Persist; Lower Rates Should Provide Relief
Introduction/Overview D.R. Horton (NYSE:DHI), the largest homebuilder in the country currently, recently popped across my radar. The reason being is…